Nonalcoholic Steatohepatitis

134 clinical trials · Condition

Record	Firm	Date
Pentoxifylline in Patients With Nonalcoholic Steatohepatitis (NCT00590161)	Case Western Reserve University	2006-12-01
The Role of Leptin Receptors in NASH (NCT00583999)	University of California, Davis	2006-01-01
Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH (NCT00267670)	Northwestern University	2005-03-01
Impact of nCPAP Treatment on Liver Function in Patients With Sleep Apnea Syndrome and Nonalcoholic Steatohepatitis (NCT00152711)	University Hospital, Angers	2004-09-01
Clearance of NRL972 in Patients With Cirrhosis, Nonalcoholic Steatohepatitis (NASH) and in Healthy Volunteers (NCT00856869)	Norgine	2004-08-01
Effects of Alanine in Patients With Nonalcoholic Steatohepatitis (NCT00586885)	Keith D Lindor, M.D.	2004-02-01
Fatty Acids, Genes and Microbiota in Fatty Liver (NCT02148471)	Johane Allard	2003-10-01
Betaine in Patients With Nonalcoholic Steatohepatitis (NCT00586911)	Mayo Clinic	2003-01-01
Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) (NCT00227110)	The University of Texas Health Science Center at San Antonio	2002-10-01
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone (NCT00013598)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	2001-03-01

Every clearance here is in the API, with alerts when new ones post.